Leu208Val and Ile181Leu variants of cytochrome P450CYP2C9 are not related to the acenocoumarol dose requirement in a Spanish population
Open Access
- 15 July 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (2) , 734-735
- https://doi.org/10.1182/blood-2002-03-0821
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarolBlood, 2002
- Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patientsBlood, 2001
- Pharmacogenetics of Warfarin Elimination and its Clinical ImplicationsClinical Pharmacokinetics, 2001
- Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatmentBlood, 2000
- Genetic Modulation of Oral Anticoagulation with WarfarinThrombosis and Haemostasis, 2000
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsThe Lancet, 1999
- Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokineticsBritish Journal of Pharmacology, 1993
- Risk Factors for Complications of Chronic Anticoagulation: A Multicenter StudyAnnals of Internal Medicine, 1993